Highlights Thermo Fisher Scientific Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 02:42:23 2024-12-12 pm EST			5-day change	1st Jan Change
526.10 ^USD	-1.55%		+1.15%	-0.74%

05:08pm	Jefferies Adjusts Price Target on Thermo Fisher Scientific to $650 From $655	MT
Dec. 09	RBC Trims Price Target on Thermo Fisher Scientific to $711 From $718, Keeps Outperform Rating	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Jefferies Adjusts Price Target on Thermo Fisher Scientific to $650 From $655	11:08am	MT
RBC Trims Price Target on Thermo Fisher Scientific to $711 From $718, Keeps Outperform Rating	Dec. 09	MT
Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	Dec. 04	CI
Nephron Research Trims Price Target on Thermo Fisher Scientific to $650 From $675	Dec. 02	MT
CMB International Initiates Thermo Fisher Scientific at Buy With $670 Price Target	Nov. 21	MT
Thermo Fisher Scientific Authorizes $4 Billion Share Buyback	Nov. 15	MT
Thermo Fisher Board Approves New $4 Billion Stock Buyback	Nov. 15	DJ
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	Nov. 15	CI
Thermo Fisher Scientific Inc. announces an Equity Buyback for $4,000 million worth of its shares.	Nov. 15	CI
Thermo Fisher Scientific Inc.'s Equity Buyback announced on November 14, 2023, has expired with 5,523,139 shares, representing 1.43% for $3,000 million.	Nov. 14	CI
Thermo Fisher Scientific Inc. authorizes a Buyback Plan.	Nov. 14	CI
Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test	Nov. 12	MT
Mainz Biomed N.V. and Thermo Fisher Scientific Inc. Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	Nov. 12	CI
Thermo Fisher Scientific Keeps Quarterly Dividend at $0.39/Share, Payable Jan. 15 to Holders on Dec. 13	Nov. 07	MT
Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2025	Nov. 07	CI
Seer Enters into A Co-Marketing and Sales Agreement with Thermo Fisher Scientific	Nov. 06	CI
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	Nov. 01	CI
Devyser Enters Collaboration to Secure US Approval for Kidney Transplant Monitoring Test	Oct. 29	MT
Devyser Enters into Agreement with Thermo Fisher Scientific to Collaborate on Obtaining U.S. Food and Drug Administration Approval for One Lambda? Devyser Accept Cfdna	Oct. 29	CI
ARC Independent Upgrades Thermo Fisher Scientific to Buy From Hold, $620 Price Target	Oct. 28	MT
Stephens Adjusts Price Target on Thermo Fisher Scientific to $670 From $680, Maintains Overweight Rating	Oct. 25	MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $645 From $680	Oct. 25	MT
Morgan Stanley Adjusts Price Target on Thermo Fisher Scientific to $670 From $680, Maintains Overweight Rating	Oct. 24	MT
Bernstein Adjusts Price Target on Thermo Fisher Scientific to $620 From $625, Maintains Market Perform Rating	Oct. 24	MT
Raymond James Adjusts Price Target on Thermo Fisher Scientific to $650 From $660, Maintains Outperform Rating	Oct. 24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Thermo Fisher opens the biotech ball with a bang

July 25, 2024 at 10:56 am EDT